美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Metsera Inc.

70.50

0.0000

成交量：- -

成交額：- -

市值：74.29億

市盈率：-11.96

高：70.50

開：70.50

低：70.50

收：70.50

52周最高：83.86

52周最低：12.30

股本：1.05億

流通股本：6,451.37萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-5.8924

每股收益(LYR):-14.4907

淨資產收益率：-134.66%

總資產收益率：-38.77%

市淨率：22.03

市盈率(LYR):-4.87

資料載入中...

總覽公司新聞資訊公告

背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場

背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場

背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場

若被「剔除」指數，這對「幣圈龍頭股」MTSR意味着什麼？

华尔街见闻

背景資料-過去十年涉及美國製藥商和生物技術公司的重大交易

輝瑞首席執行官阿爾伯特·布爾拉表示，Think Co將全額支付Metsera的CVR

諾和諾德表示不會提高收購Metsera, Inc.的提議

Metsera就訴訟裁決發布聲明

輝瑞向Metsera提交了增價收購提案，與諾和諾德的出價相匹配，評估Metsera每股價值為86.20美元

輝瑞(PFE.US)擬發行50億美元債券為收購減肥藥企Metsera籌措資金

減肥藥要降價65%，兩大跨國藥企為何股價反倒高漲？

背景資料-過去十年涉及美國製藥商和生物技術公司的重大交易

輝瑞(PFE)宣佈成功完成對生物製藥公司Metsera的收購

輝瑞完成收購Metsera

今日優惠-合併與收購

背景資料-輝瑞和諾和諾德競購戰的目標 Metsera 是什麼？

輝瑞完成對美塞拉高達 100 億美元的收購

Metsera選舉監察員宣佈多數有投票權股東已通過合併協議提案，初步計票結果顯示

美特斯邦威股東投票讚成輝瑞以 100 億美元收購美特斯邦威

Metsera股東初步計票通過輝瑞高達100億美元的收購提案

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MTSR/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MTSR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","market":"US","secType":"STK","nameCN":"Metsera Inc.","latestPrice":70.5,"timestamp":1770670800000,"preClose":70.5,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":64513712,"shares":105376189,"eps":-5.892395,"marketStatus":"未開盤","change":0,"latestTime":"02-09 16:00:00 EST","open":70.5,"high":70.5,"low":70.5,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.892395,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":0,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":70.5,"volumeRatio":0,"impliedVol":0.3139,"impliedVolPercentile":0.2016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","floatShares":64513712,"roa":"-38.77%","roe":"-134.66%","lyrEps":-14.490661,"shares":105376189,"dividePrice":0,"high":70.5,"amplitude":0,"preClose":70.5,"low":70.5,"week52Low":12.3,"pbRate":"22.03","week52High":83.8599,"institutionHeld":0,"latestPrice":70.5,"eps":-5.892395,"divideRate":0,"volume":0,"delay":0,"ttmEps":-5.892395,"open":70.5,"prevYearClose":70.5,"prevWeekClose":70.5,"prevMonthClose":70.5,"prevQuarterClose":70.5,"fiveDayClose":70.5,"twentyDayClose":70.5,"sixtyDayClose":70.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTSR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"MTSR","reason":null,"defaultRemindTime":1763130600000,"announcedDate":"2025-11-12","type":"delisting","dateTimestamp":1763096400000},{"market":"US","date":"2025-11-12","symbol":"MTSR","fiscalQuarterEnding":"2025/09","expectedEps":-0.56,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-1.11},{"market":"US","date":"2025-07-28","symbol":"MTSR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1753675200000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-05-12","symbol":"MTSR","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-1.03},{"market":"US","date":"2025-03-26","symbol":"MTSR","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"pre","actualEps":-3.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTSR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTSR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1761886800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MTSR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MTSR","date":"2025-11-14","current":-11.964575,"percent":0.036082,"low":-55.8522,"twenty":-17.976689,"median":-12.456963,"eighty":-10.995731,"high":-6.570442,"avg":-14.489177,"sd":5.001483,"marketCap":7429021324},"quantilePoints":[{"date":"2025-02-07","current":-17.973411,"twenty":-17.939327,"median":-17.8882,"eighty":-17.837073,"marketCap":3042628924},{"date":"2025-02-14","current":-18.277736,"twenty":-18.639274,"median":-18.277736,"eighty":-17.958804,"marketCap":3094146515},{"date":"2025-02-21","current":-19.257661,"twenty":-19.263748,"median":-18.612493,"eighty":-17.973411,"marketCap":3260033158},{"date":"2025-02-28","current":-15.222317,"twenty":-19.263748,"median":-18.292952,"eighty":-17.802989,"marketCap":2576909901},{"date":"2025-03-07","current":-16.749262,"twenty":-19.257661,"median":-17.973411,"eighty":-16.634383,"marketCap":2835398748},{"date":"2025-03-14","current":-15.094245,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":2555229332},{"date":"2025-03-21","current":-17.309229,"twenty":-18.72205,"median":-17.732316,"eighty":-15.847091,"marketCap":2930192911},{"date":"2025-03-28","current":-15.074845,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":3152557072},{"date":"2025-04-04","current":-10.624224,"twenty":-18.709149,"median":-17.433667,"eighty":-15.417782,"marketCap":2221812131},{"date":"2025-04-11","current":-6.570442,"twenty":-18.612493,"median":-16.926585,"eighty":-14.065167,"marketCap":1374056864},{"date":"2025-04-17","current":-8.815846,"twenty":-18.585291,"median":-16.597864,"eighty":-11.231036,"marketCap":1843631343},{"date":"2025-04-25","current":-10.639294,"twenty":-18.362232,"median":-16.039969,"eighty":-10.465489,"marketCap":2224963638},{"date":"2025-05-02","current":-11.734368,"twenty":-18.283822,"median":-15.629326,"eighty":-9.926993,"marketCap":2453973115},{"date":"2025-05-09","current":-12.437626,"twenty":-18.170614,"median":-15.417782,"eighty":-10.4896,"marketCap":2601043422},{"date":"2025-05-16","current":-10.120836,"twenty":-18.143134,"median":-15.084545,"eighty":-9.926993,"marketCap":2690472328},{"date":"2025-05-23","current":-11.083125,"twenty":-18.007321,"median":-13.673351,"eighty":-10.08689,"marketCap":2946282563},{"date":"2025-05-30","current":-10.903313,"twenty":-17.962456,"median":-12.437626,"eighty":-10.237022,"marketCap":2898482293},{"date":"2025-06-06","current":-11.330119,"twenty":-17.863854,"median":-12.078462,"eighty":-10.380871,"marketCap":3011942274},{"date":"2025-06-13","current":-13.665697,"twenty":-17.760585,"median":-12.111113,"eighty":-10.505751,"marketCap":3632820504},{"date":"2025-06-20","current":-10.950736,"twenty":-17.702451,"median":-12.009847,"eighty":-10.478878,"marketCap":2911088957},{"date":"2025-06-27","current":-11.345927,"twenty":-17.568059,"median":-11.719298,"eighty":-10.542899,"marketCap":3016144495},{"date":"2025-07-03","current":-11.638368,"twenty":-17.408779,"median":-11.681839,"eighty":-10.571353,"marketCap":3093885594},{"date":"2025-07-11","current":-14.388896,"twenty":-17.268165,"median":-11.697647,"eighty":-10.619566,"marketCap":3825072138},{"date":"2025-07-18","current":-17.506951,"twenty":-17.303722,"median":-11.789624,"eighty":-10.623027,"marketCap":4653960333},{"date":"2025-07-25","current":-15.67129,"twenty":-17.246135,"median":-12.009847,"eighty":-10.627238,"marketCap":4165977359},{"date":"2025-08-01","current":-11.259046,"twenty":-17.080186,"median":-12.060267,"eighty":-10.669177,"marketCap":3465782198},{"date":"2025-08-08","current":-10.542344,"twenty":-16.963959,"median":-11.907491,"eighty":-10.669177,"marketCap":3245165568},{"date":"2025-08-15","current":-10.340985,"twenty":-16.859629,"median":-11.799396,"eighty":-10.571353,"marketCap":3183182801},{"date":"2025-08-22","current":-11.194202,"twenty":-16.776854,"median":-11.704228,"eighty":-10.619566,"marketCap":3445821646},{"date":"2025-08-29","current":-11.958684,"twenty":-16.726286,"median":-11.700938,"eighty":-10.623027,"marketCap":3681146051},{"date":"2025-09-05","current":-12.385292,"twenty":-16.634383,"median":-11.74414,"eighty":-10.624224,"marketCap":3812465474},{"date":"2025-09-12","current":-12.712928,"twenty":-16.561345,"median":-11.903146,"eighty":-10.627666,"marketCap":3913318790},{"date":"2025-09-19","current":-12.252191,"twenty":-16.438168,"median":-11.874013,"eighty":-10.639294,"marketCap":3771493814},{"date":"2025-09-26","current":-17.959018,"twenty":-16.749262,"median":-11.907491,"eighty":-10.774419,"marketCap":5528180703},{"date":"2025-10-03","current":-17.681988,"twenty":-17.103908,"median":-11.968922,"eighty":-10.788708,"marketCap":5442905015},{"date":"2025-10-10","current":-17.989799,"twenty":-17.506951,"median":-12.044006,"eighty":-10.863794,"marketCap":5537655780},{"date":"2025-10-17","current":-18.078722,"twenty":-17.750391,"median":-12.092917,"eighty":-10.890458,"marketCap":5565028223},{"date":"2025-10-24","current":-18.000059,"twenty":-17.870095,"median":-12.173695,"eighty":-10.903313,"marketCap":5540814139},{"date":"2025-10-31","current":-21.796385,"twenty":-17.928237,"median":-12.282118,"eighty":-10.950736,"marketCap":6709406898},{"date":"2025-11-07","current":-27.891028,"twenty":-17.959018,"median":-12.385292,"eighty":-10.986017,"marketCap":8585472031},{"date":"2025-11-14","current":-24.134147,"twenty":-17.976689,"median":-12.456963,"eighty":-10.995731,"marketCap":7429021324}],"updateTime":1770691594113},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MTSR\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2590505938","title":"背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2590505938","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590505938?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 20:04","pubTimestamp":1765541053,"startTime":"0","endTime":"0","summary":"背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场修改日期线，在第 19、20、27、36 和 54 段增加新的细节。今年8月，该制药公司称其试验性减肥药orforglipron ，在一项晚期试验中，以36毫克的最高剂量服用72周，可帮助患有2型糖尿病的超重成年人减轻10.5%的体重。服用最高剂量Ozempic的糖尿病患者体重大约减轻了6%。礼来公司希望在今年年底前获得监管部门对orfglipron的批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL4S3XI0UM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","LU1116320901.HKD","LU1084165304.USD","LU2023250504.SGD","LU0784383803.USD","LU0058720904.USD","LU2237443622.USD","LU2361044865.SGD","GPCR","IE00BFTCPJ56.SGD","LU0234572021.USD","LU0575583348.USD","AMGN","LU0786609619.USD","OPK","MRK","600196","VKTX","03933","LU2491050154.USD","LU1003076772.USD","LU1057294990.SGD","LU2114397693.USD","BK4588","LU0949170772.SGD","LU0203345920.USD","BK0183","03165","00656","02105","LU1066051811.HKD","SRRK","LU0345777659.USD","LU1917777945.USD","AZN.UK","LU1929549753.HKD","LU0310800379.SGD","IE0002141913.USD","LU1894683348.USD","ALT","MTSR","PFE","LU0969580561.USD","LU1989772923.USD","LU1551013425.SGD","LLY","LU0689472784.USD","LU1037948897.HKD","03692","SG9999014914.USD"],"gpt_icon":1},{"id":"2589535914","title":"背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2589535914","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589535914?lang=zh_tw&edition=fundamental","pubTime":"2025-12-08 22:29","pubTimestamp":1765204182,"startTime":"0","endTime":"0","summary":"背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场更改日期线，重写标题，增加有关 Structure Therapeutics 公司最新数据的详细信息。诺和诺德计划在 2026 年第一季度将 CagriSema 提交监管部门审批。今年 9 月，MET-097i 在两项中期试验中显示，28 周后平均体重下降 14.1%。服用最高剂量Ozempic的糖尿病患者大约减轻了6%的体重。西兰制药 丹麦生物技术公司西兰制药ZELA.CO去年表示，在一项早期研究中，其减肥候选药物petrelintide的高剂量在每周服用16次后，体重平均减轻了8.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL4T3XE15C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0005OL40V9.USD","SG9999003800.SGD","LU0823416689.USD","OPK","BK4196","LU1037948897.HKD","AMGN","BK1191","LU0238689110.USD","LU2471134952.CNY","SRRK","GPCR","SG9999014559.SGD","LU0889565916.HKD","LU2491050154.USD","LU1623119135.USD","LU0784385170.HKD","MTSR","AZN.UK","LU0672654240.SGD","LU0889565080.SGD","LU2023251221.USD","LU1232071149.USD","SG9999018865.SGD","BK1583","LU0786609619.USD","VKTX","LU1974910355.USD","LU0960981461.USD","IE0034235188.USD","LU2471134523.USD","ALT","SG9999017495.SGD","LU1261432733.SGD","03165","MRK","LU1267930813.SGD","IE00B3T34201.USD","IE00BN8TJ469.HKD","LU1934455863.HKD","LU1104425308.USD","IE0002270589.USD","LU1496350502.SGD","02105","03692","03933","LU0456855351.SGD","LU0943347566.SGD"],"gpt_icon":1},{"id":"2586475794","title":"背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2586475794","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586475794?lang=zh_tw&edition=fundamental","pubTime":"2025-11-25 21:39","pubTimestamp":1764077953,"startTime":"0","endTime":"0","summary":"背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场改写第1段，在第3段增加礼来估值里程碑，更新第9-0段诺和诺德试验细节。在其中一项试验中，该药帮助超重患者减轻了22.7%的体重，低于诺和诺德25%的预期。诺和诺德计划在 2026 年第一季度将 CagriSema 提交监管部门审批。今年 9 月，MET-097i 在两项中期试验中显示，28 周后平均体重下降 14.1%。服用最高剂量Ozempic的糖尿病患者体重大约减轻了6%。礼来公司希望在今年年底前获得监管部门对orfglipron的批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nL4S3X10WR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109391861.USD","02105","BK4592","MRK","LU1057294990.SGD","SG9999014542.SGD","03692","LU1023059063.AUD","LU1069347547.HKD","MTSR","LU0820561909.HKD","SG9999015986.USD","LU0094547139.USD","LLY","VKTX","LU2746668461.USD","ALT","LU0553294199.USD","LU2168564149.EUR","03933","LU0225771236.USD","SG9999011175.SGD","LU2063271972.USD","03165","IE0004445239.USD","IE00B4R5TH58.HKD","LU0265550359.USD","AMGN","LU0353189680.USD","LU0823416689.USD","LU0964806797.USD","LU0079474960.USD","LU1061106388.HKD","LU1066051225.USD","LU1551013342.USD","LU2168564065.EUR","LU0198837287.USD","AZN.UK","IE00BLSP4239.USD","LU2168563687.JPY","LU0738911758.USD","SG9999015945.SGD","GPCR","LU0557290698.USD","LU0949170772.SGD","SG9999013999.USD","OPK","LU2265009873.SGD","SRRK"],"gpt_icon":1},{"id":"2585921120","title":"若被「剔除」指數，這對「幣圈龍頭股」MTSR意味着什麼？","url":"https://stock-news.laohu8.com/highlight/detail?id=2585921120","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585921120?lang=zh_tw&edition=fundamental","pubTime":"2025-11-22 11:26","pubTimestamp":1763781974,"startTime":"0","endTime":"0","summary":"指数提供商MSCI提议，可能将其全球可投资市场指数中的“数字资产财库公司”剔除，而MicroStrategy是此类公司的典型代表。据摩根大通分析，若被剔除，MicroStrategy的估值将面临“相当大的压力”，可能引发追踪MSCI指数的基金抛售约28亿美元的股票。过去一年，该公司股价已跌57%。","market":"nz","thumbnail":"https://static.tigerbbs.com/962be253ee7459c393769e9105cb1429","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/962be253ee7459c393769e9105cb1429"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3759918","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3759918","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTSR"],"gpt_icon":1},{"id":"2584155354","title":"背景資料-過去十年涉及美國製藥商和生物技術公司的重大交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2584155354","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584155354?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 23:52","pubTimestamp":1763653969,"startTime":"0","endTime":"0","summary":"在过去十年中，美国制药公司为收购从肿瘤学、神经学到罕见病和肥胖症等领域前景看好的疗法而进行的引人注目的交易越来越多，此举为这一交易增添了新的亮点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nL4T3WW1BK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTSR","GILD","03165","LU2279689827.SGD","LU0784385840.USD","LU1032955483.USD","LU0047473722.EUR","LU2242652126.USD","IE0009355771.USD","LU1430594728.SGD","LU1267930573.SGD","SG9999015952.SGD","IE00B3T34201.USD","LU2324357040.USD","BK5011","LU0868494617.USD","MRK","LU0106261372.USD","SG9999015341.SGD","LU0963555726.SGD","LU1481600234.SGD","JNJ","AZN.UK","LU0526926950.USD","SG9999001176.USD","LU1291159041.SGD","LU0114720955.EUR","LU2237443465.HKD","LU1003076772.USD","CDTX","LU1721429741.USD","LU1267930490.SGD","BK4585","AMGN","IE00BGHQF631.EUR","BMY","LU2125154935.USD","BK4516","LU0466842654.USD","BK4139","LU1061106388.HKD","LU0689626769.HKD","EXAS","LU1868837300.USD","ABBV","ABT","VTRS","LU0661504455.SGD","LU0029864427.USD"],"gpt_icon":1},{"id":"1173736428","title":"輝瑞首席執行官阿爾伯特·布爾拉表示，Think Co將全額支付Metsera的CVR","url":"https://stock-news.laohu8.com/highlight/detail?id=1173736428","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173736428?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 01:21","pubTimestamp":1763572880,"startTime":"0","endTime":"0","summary":"11月10日 - 辉瑞首席执行官阿尔伯特·布尔拉在接受CNBC采访时表示，Think Co将全额支付Metsera的CVR。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU0225771236.USD","BK4592","IE000M9KFDE8.USD","LU1883839398.USD","LU0234572021.USD","PFE","IE00BLSP4452.SGD","TURA","BK4588","MTSR","LU0058720904.USD","BK4568","BK4533","LU1066053197.SGD","LU1057294990.SGD","LU0306806265.USD","LU1066051498.USD","BK4581","LU0868494617.USD","SGXZ57979304.SGD","LU0456855351.SGD","LU0985481810.HKD","LU1023059063.AUD","IE0002270589.USD","LU0306807586.USD","SG9999002224.SGD","LU0321505439.SGD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU1894683264.USD","SG9999001176.SGD","BK4585","LU1894683348.USD","BK4534","LU0170899867.USD","SG9999001176.USD","BK4599","BK4139","LU0289739699.SGD","SG9999011175.SGD","LU0122379950.USD","BK4007","IE00BBT3K403.USD","IE00BLSP4239.USD","SG9999002232.USD","BK4082","SG9999003800.SGD","LU0225284248.USD","SG9999013999.USD","BK4550"],"gpt_icon":0},{"id":"1153193567","title":"諾和諾德表示不會提高收購Metsera, Inc.的提議","url":"https://stock-news.laohu8.com/highlight/detail?id=1153193567","media":"投资观察","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153193567?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 01:14","pubTimestamp":1763572462,"startTime":"0","endTime":"0","summary":"11月8日（路透社）- 诺和诺德A/S：*诺和诺德不会提高收购Metsera, Inc.的提议。*诺和诺德 - 将不会提高对Metsera的报价。*诺和诺德：相信我们潜在的合并协议结构符合反垄断法。*诺和诺德：公司将不会提高收购Metsera的报价，以保持对财务纪律和股东价值的承诺。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTSR","BK4139"],"gpt_icon":0},{"id":"1114557893","title":"Metsera就訴訟裁決發布聲明","url":"https://stock-news.laohu8.com/highlight/detail?id=1114557893","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114557893?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 00:48","pubTimestamp":1763570923,"startTime":"0","endTime":"0","summary":"11月5日 - Metsera Inc.发布声明回应诉讼裁决。Metsera Inc.表示：“Metsera对特拉华州衡平法院驳回辉瑞临时限制令请求的决定表示满意。”","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTSR"],"gpt_icon":0},{"id":"1134214449","title":"輝瑞向Metsera提交了增價收購提案，與諾和諾德的出價相匹配，評估Metsera每股價值為86.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134214449","media":"投资观察","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134214449?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 00:45","pubTimestamp":1763570719,"startTime":"0","endTime":"0","summary":"11月5日 - 辉瑞已提交其增价收购Metsera的提案，与诺和诺德的出价相匹配，评估Metsera每股价值为86.20美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e1fbf767b72786c619addd4b3b99990","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","SG9999001176.USD","BK4007","LU0321505439.SGD","BK4533","IE00BLSP4452.SGD","SG9999011175.SGD","MTSR","IE00B19Z3B42.SGD","LU0225284248.USD","LU1894683264.USD","BK4588","IE00B19Z3581.USD","BK4139","BK4550","LU0170899867.USD","LU0306807586.USD","LU0289739699.SGD","LU0122379950.USD","BK4581","LU0058720904.USD","LU1057294990.SGD","LU0225771236.USD","IE0002270589.USD","BK4534","LU1883839398.USD","SGXZ57979304.SGD","SG9999013999.USD","BK4592","LU0321505868.SGD","SG9999001176.SGD","LU0234572021.USD","BK4568","LU0868494617.USD","SG9999003800.SGD","LU1066051498.USD","LU1023059063.AUD","LU0306806265.USD","SG9999002232.USD","IE00BBT3K403.USD","LU1894683348.USD","IE000M9KFDE8.USD","BK4599","LU1066053197.SGD","LU0985481810.HKD","BK4585","IE00BLSP4239.USD","PFE","SG9999002224.SGD"],"gpt_icon":0},{"id":"2584005996","title":"輝瑞(PFE.US)擬發行50億美元債券 為收購減肥藥企Metsera籌措資金","url":"https://stock-news.laohu8.com/highlight/detail?id=2584005996","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584005996?lang=zh_tw&edition=fundamental","pubTime":"2025-11-19 10:58","pubTimestamp":1763521135,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据知情人士透露，辉瑞正计划通过发行美元公司债券募集至少50亿美元资金，部分用于资助近期对肥胖症药物研发公司Metsera的收购交易。据了解，周二当天，辉瑞与其他八家机构一同启动投资级债券发行融资。此前一日，受亚马逊150亿美元投资级债券发行推动，市场完成了263亿美元的融资交易。这家新冠疫苗研发企业经过激烈竞标，最终以最高100亿美元的对价完成对Metsera的收购，其中包含与或有价值权利挂钩的每股20.65美元现金额外付款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370867.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1023059063.AUD","SG9999002224.SGD","BK4585","IE00B19Z3581.USD","PFE","LU0321505439.SGD","BK4581","BK4592","BK4568","LU1066051498.USD","LU0306807586.USD","SG9999003800.SGD","SG9999013999.USD","IE00BLSP4239.USD","LU0868494617.USD","IE00BLSP4452.SGD","LU0985481810.HKD","SG9999002232.USD","LU0289739699.SGD","BK4007","LU1894683264.USD","MTSR","BK4599","LU0058720904.USD","LU0234572021.USD","LU1057294990.SGD","SG9999001176.USD","SG9999011175.SGD","SGXZ57979304.SGD","LU0456855351.SGD","SG9999001176.SGD","LU1883839398.USD","LU0170899867.USD","LU1066053197.SGD","BK4534","BK4550","LU0225284248.USD","LU1894683348.USD","LU0122379950.USD","BK4533","BK4588","LU0306806265.USD","BK4139","IE00BBT3K403.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","IE0002270589.USD","LU0225771236.USD","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2583650368","title":"減肥藥要降價65%，兩大跨國藥企為何股價反倒高漲？","url":"https://stock-news.laohu8.com/highlight/detail?id=2583650368","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583650368?lang=zh_tw&edition=fundamental","pubTime":"2025-11-16 09:00","pubTimestamp":1763254800,"startTime":"0","endTime":"0","summary":"　　这个11月，医药市场一年都未必能凑齐的各种反转，全让三大巨头在减肥药上演完了。Metsera此前已与辉瑞达成初步意向，但在10月30日，诺和诺德突然宣布高价“截胡”，三方两度闹上法庭。　　11月6日，特朗普宣布，减肥药降价至245美元/月，降幅至少达65%。一名参与白宫药价谈判的药企代表直接晕倒在现场。　　这是减肥药被降价后，生产商的股价不降反升的一个重要原因。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-11-16/doc-infxqeca2425707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4550","IE00BLSP4239.USD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU0321505868.SGD","LU0456855351.SGD","LU0306806265.USD","LU0321505439.SGD","SG9999002232.USD","LU1066051498.USD","NVO","BK4585","LU1023059063.AUD","IE000M9KFDE8.USD","BK4599","BK4532","IE00BLSP4452.SGD","SG9999011175.SGD","LU0289739699.SGD","LU0306807586.USD","LU1066053197.SGD","IE00BKVL7J92.USD","LU1093756168.USD","BK4581","LU0170899867.USD","BK4534","IE00B19Z3581.USD","LU0225284248.USD","BK4007","IE00BBT3K403.USD","MTSR","IE0002270589.USD","BK4588","SG9999001176.USD","IE00BZ1G4Q59.USD","LU0154236417.USD","SG9999001176.SGD","BK4568","SG9999003800.SGD","LU1894683264.USD","BK4592","LU0234572021.USD","LU0058720904.USD","SG9999013999.USD","LU0225771236.USD","LU1093756325.SGD","BK4139","LU0868494617.USD","LU1883839398.USD","PFE"],"gpt_icon":1},{"id":"2583503644","title":"背景資料-過去十年涉及美國製藥商和生物技術公司的重大交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2583503644","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583503644?lang=zh_tw&edition=fundamental","pubTime":"2025-11-14 20:10","pubTimestamp":1763122210,"startTime":"0","endTime":"0","summary":"过去十年来，美国制药公司收购从肿瘤学、神经病学到罕见病和肥胖症等领域前景看好的疗法的高调交易不断增多，此举为这一交易增添了新的亮点。根据LSEG编制的数据，截至今年7月9日，全球已签署了价值1053亿美元的制药和生物技术并购交易，比去年同期增长了7%，创下了自2023年以来的最高纪录。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nL4S3WQ10D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836757.USD","LU2505996509.AUD","LU1551013342.USD","LU1989772840.SGD","JNJ","IE00BKVL7J92.USD","LU2237443382.USD","MTSR","LU0963555726.SGD","LU1880407132.USD","LU1868836914.USD","AZN.UK","CDTX","LU2091194634.USD","LU1917777945.USD","LU0225771236.USD","LU1989772923.USD","LU0526926950.USD","LU0238689110.USD","LU0077335932.USD","LU2505996681.GBP","ABBV","GILD","IE000M9KFDE8.USD","LU1032955483.USD","LU1496350171.SGD","LU1989771016.USD","MRK","LU0070302665.USD","LU0306807586.USD","SG9999014575.USD","AMGN","LU0061475181.USD","LU1066051498.USD","LU0661504455.SGD","VTRS","BMY","LU1868836591.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","03165","LU0096364046.USD","LU0557290698.USD","LU1868837136.USD","LU0158827948.USD","LU0889566641.SGD","LU0466842654.USD","LU2602419157.SGD","IE00BJJMRZ35.SGD"],"gpt_icon":1},{"id":"2583576621","title":"輝瑞(PFE)宣佈成功完成對生物製藥公司Metsera的收購","url":"https://stock-news.laohu8.com/highlight/detail?id=2583576621","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583576621?lang=zh_tw&edition=fundamental","pubTime":"2025-11-14 16:49","pubTimestamp":1763110199,"startTime":"0","endTime":"0","summary":"金吾财讯 | 辉瑞(PFE)宣布成功完成对Metsera公司的收购。Metsera是一家临床阶段的生物制药公司，致力于开发针对肥胖症及心血管代谢疾病的新一代药物。7日，辉瑞同意以100亿美元收购Metsera，此前该公司与诺和诺德就后者展开激烈竞购。Metsera宣布，已与辉瑞达成修订版合并协议。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/Nzg4NjU0MjU3NDIxMDY0.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Nzg4NjU0MjU3NDIxMDY0.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"294444","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","BK4592","IE00B19Z3581.USD","LU0985481810.HKD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0170899867.USD","LU0289739699.SGD","LU0456855351.SGD","BK4534","SG9999011175.SGD","IE0002270589.USD","IE000M9KFDE8.USD","SG9999002224.SGD","LU1894683264.USD","BK4139","BK4007","LU0306806265.USD","SG9999013999.USD","LU1894683348.USD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4585","SG9999001176.SGD","SG9999002232.USD","BK4588","PFE","LU0225284248.USD","BK4550","LU0058720904.USD","IE00BLSP4239.USD","LU1883839398.USD","SG9999003800.SGD","LU0321505439.SGD","IE00BBT3K403.USD","LU1066051498.USD","LU0868494617.USD","SG9999001176.USD","MTSR","LU1023059063.AUD","LU1057294990.SGD","BK4533","LU0306807586.USD","LU0321505868.SGD","BK4568","SGXZ57979304.SGD","LU0225771236.USD","BK4599","BK4581"],"gpt_icon":0},{"id":"2583054551","title":"輝瑞完成收購Metsera","url":"https://stock-news.laohu8.com/highlight/detail?id=2583054551","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583054551?lang=zh_tw&edition=fundamental","pubTime":"2025-11-14 07:54","pubTimestamp":1763078059,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0306807586.USD","LU1883839398.USD","IE00BLSP4452.SGD","LU0985481810.HKD","SG9999011175.SGD","LU0321505868.SGD","LU0058720904.USD","LU0306806265.USD","IE00BLSP4239.USD","LU0234572021.USD","BK4533","LU0122379950.USD","LU0321505439.SGD","BK4568","SGXZ57979304.SGD","BK4534","SG9999002224.SGD","LU0456855351.SGD","LU1057294990.SGD","BK4007","BK4588","SG9999003800.SGD","SG9999002232.USD","LU0170899867.USD","SG9999001176.USD","LU0225284248.USD","LU1894683264.USD","BK4585","LU0289739699.SGD","BK4581","BK4550","LU0225771236.USD","LU0868494617.USD","LU1894683348.USD","SG9999013999.USD","LU1066051498.USD","LU1023059063.AUD","MTSR","IE000M9KFDE8.USD","IE0002270589.USD","BK4592","PFE","SG9999001176.SGD","IE00B19Z3B42.SGD","BK4139","IE00BBT3K403.USD","LU1066053197.SGD","IE00B19Z3581.USD","BK4599"],"gpt_icon":0},{"id":"2583174585","title":"今日優惠-合併與收購","url":"https://stock-news.laohu8.com/highlight/detail?id=2583174585","media":"路透中文","labels":["corporation","merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583174585?lang=zh_tw&edition=fundamental","pubTime":"2025-11-14 05:50","pubTimestamp":1763070608,"startTime":"0","endTime":"0","summary":"今日优惠-合并与收购添加卢克石油公司、LKQ、雷普索尔公司路透11月13日 - 截至格林尼治标准时间周四21:30 ，报导了以下竞标、兼并、收购和处置情况：** 三位熟悉情况的消息人士称，美国私募股权巨头凯雷正在探索收购俄罗斯石油巨头卢克石油公司 >海外资产的方案  。nL4N3WP1FC ** 德意志银行DBKGn.DE投资部门DWS集团DWSG.DE将收购日本人寿印度资产管理NIPF.NS部门40%的股份，以建立另类投资基金专营权，这家德国公司希望扩大其在亚洲的业务范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL4T3WP1PW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","LU2098885051.SGD","BK4183","EPC","LU0289739699.SGD","LU1066053197.SGD","IE000M9KFDE8.USD","IE00B42XCP33.USD","LU1599440770.SGD","LU1066051498.USD","BK4599","SGXZ57979304.SGD","MTSR","LU0130102774.USD","BK4533","LKQ","LU0208291251.USD","BK4568","LU0234572021.USD","LU1670628061.USD","LU0980610538.SGD","BK4504","BK4007","APA","IE00BLSP4239.USD","SG9999011175.SGD","BK4139","LU0321505868.SGD","LU2041044095.USD","LU0070302665.USD","LU0058720904.USD","IE00BVYPNV92.GBP","IE00B19Z3B42.SGD","BK4535","BK4534","LU0731783048.USD","LU1201861249.SGD","BK4567","LU0648001328.SGD","LU1303367103.USD","LU1894683348.USD","SG9999001176.USD","LU0306807586.USD","BK4581","BK4592","LU1057294990.SGD","LU1366333091.USD","LU1989771016.USD","BLK"],"gpt_icon":1},{"id":"2583659033","title":"背景資料-輝瑞和諾和諾德競購戰的目標 Metsera 是什麼？","url":"https://stock-news.laohu8.com/highlight/detail?id=2583659033","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583659033?lang=zh_tw&edition=fundamental","pubTime":"2025-11-14 01:07","pubTimestamp":1763053654,"startTime":"0","endTime":"0","summary":"更新版 1-背景资料-辉瑞和诺和诺德竞购战的目标 Metsera 是什么？改写第1段，增加交易完成的细节，在第6段增加辉瑞修正报价的背景信息。诺和诺德的减肥药 Wegovy 和礼来的 Zepbound 和 Mounjaro 需要每周注射一次。所有权和支持者Arch Venture Partners 是 Metsera 的最大股东，通过其 ARCH Venture Fund XII 和 XIII 持有超过25% 的股份，该基金由投资者 Bob Nelsen 领导。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL4S3WP1HH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE","LU1868837136.USD","LU0314104364.USD","LU2097829019.USD","LU1280957306.USD","LU1791710400.SGD","LU2028103732.USD","BK4543","LU2065170008.USD","SG9999014914.USD","LU2750360641.GBP","LU2491050154.USD","LU2750360997.AUD","IE00B1BXHZ80.USD","LU1196500208.SGD","LU2491050071.SGD","MTSR","IE00BJJMRZ35.SGD","LU0094547139.USD","LU1868836591.USD","LU1116320901.HKD","LU2360106947.USD","LU2092937148.SGD","SG9999017495.SGD","LU0345768740.USD","LU0267386448.USD","IE0009355771.USD","BK4007","LU1066051225.USD","LU0251132253.USD","LU0251131958.USD","LU0130518102.USD","LU0426417589.USD","LU2491049909.HKD","LU2860962120.EUR","LU1232071149.USD","IE0034235303.USD","LU0661504455.SGD","LU1791710582.SGD","LU0316494557.USD","LU0149725797.USD","LU1145028129.USD","LU2092627202.USD","LU2468319806.SGD","LU2324357040.USD","LU0456855351.SGD","LU1868836914.USD","LU1815336760.USD"],"gpt_icon":1},{"id":"2583459641","title":"輝瑞完成對美塞拉高達 100 億美元的收購","url":"https://stock-news.laohu8.com/highlight/detail?id=2583459641","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583459641?lang=zh_tw&edition=fundamental","pubTime":"2025-11-13 22:24","pubTimestamp":1763043889,"startTime":"0","endTime":"0","summary":"更新版 4-辉瑞完成对美塞拉高达 100 亿美元的收购交易标志着辉瑞重新进入肥胖症治疗市场辉瑞股价上涨1.4%，诺和诺德下跌1.3Metsera候选药物MET-097i进入后期试验阶段辉瑞宣布完成交易并更新股价，重新修订了报道文字和标题Kamal  Choudhury/Mariam Sunny. 路透11月13日 - 辉瑞PFE.N周四在获得股东批准后完成了对MetseraMTSR.O高达100亿美元的收购，在与诺和诺德NOVOb.CO激烈的竞购战后，辉瑞在快速增长的肥胖症市场获得了一席之地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL4S3WP13B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","LU0820561818.USD","LU1868837300.USD","LU1069344957.HKD","BK4550","BK4599","LU2236285917.USD","LU0708995401.HKD","LU2237443465.HKD","IE00BLSP4239.USD","LU0267386448.USD","LU2125154778.USD","LU2242646821.SGD","SG9999001176.USD","PFE","BK4585","LU0385154629.USD","LU0889565916.HKD","LU1894683264.USD","IE00B1BXHZ80.USD","LU0225284248.USD","LU1232071149.USD","LU0316494557.USD","BMY","IE00BFTCPJ56.SGD","IE00BWXC8680.SGD","LU0432979614.USD","IE00BKDWB100.SGD","IE00B19Z3581.USD","LU1814569148.SGD","LU2360106947.USD","LU2133065610.SGD","LU2324357040.USD","SG9999011175.SGD","BK4559","IE00BJLML261.HKD","LU0061475181.USD","LU0786609619.USD","SGXZ57979304.SGD","LU0006306889.USD","LU2456880835.USD","MTSR","LU1064131342.USD","BK4588","LU1261432733.SGD","LU0094547139.USD","LU1718418525.SGD","LU0234572021.USD","LU1551013342.USD"],"gpt_icon":1},{"id":"1118820259","title":"Metsera選舉監察員宣佈多數有投票權股東已通過合併協議提案，初步計票結果顯示","url":"https://stock-news.laohu8.com/highlight/detail?id=1118820259","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118820259?lang=zh_tw&edition=fundamental","pubTime":"2025-11-13 22:16","pubTimestamp":1763043378,"startTime":"0","endTime":"0","summary":"Metsera选举监察员宣布多数有投票权股东已通过合并协议提案，初步计票结果显示","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","BK4592","BK4550","LU1066051498.USD","LU1894683264.USD","LU0306806265.USD","LU0985481810.HKD","LU0289739699.SGD","BK4139","SG9999001176.SGD","IE00BLSP4239.USD","LU0225284248.USD","PFE","LU0122379950.USD","LU1057294990.SGD","IE00B19Z3581.USD","LU1023059063.AUD","LU1066053197.SGD","LU0234572021.USD","BK4007","LU0170899867.USD","BK4533","BK4599","LU0225771236.USD","SGXZ57979304.SGD","LU1894683348.USD","BK4585","LU1883839398.USD","LU0321505439.SGD","SG9999002232.USD","BK4568","SG9999003800.SGD","SG9999013999.USD","BK4534","BK4581","LU0306807586.USD","IE00BLSP4452.SGD","LU0321505868.SGD","LU0868494617.USD","MTSR","SG9999002224.SGD","BK4588","LU0456855351.SGD","IE0002270589.USD","SG9999001176.USD","IE00BBT3K403.USD","LU0058720904.USD","IE000M9KFDE8.USD","SG9999011175.SGD"],"gpt_icon":0},{"id":"2583380596","title":"美特斯邦威股東投票讚成輝瑞以 100 億美元收購美特斯邦威","url":"https://stock-news.laohu8.com/highlight/detail?id=2583380596","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583380596?lang=zh_tw&edition=fundamental","pubTime":"2025-11-13 22:13","pubTimestamp":1763043222,"startTime":"0","endTime":"0","summary":"美特斯邦威股东投票赞成辉瑞以 100 亿美元收购美特斯邦威路透11月13日 - 美塞拉MTSR.O的股东周四批准了 辉瑞 >价值高达100亿美元的收购要约，使 这家美国制药巨头在与Wegovy生产商诺和诺德NOVOb.CO展开激烈竞购战后，得以 重新进入利润丰厚的肥胖症治疗市场。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL4T3WP128:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","LU1261432733.SGD","IE00B1XK9C88.USD","LU1883839398.USD","LU1366192091.USD","LU2357305700.SGD","LU1267930730.SGD","LU0323591593.USD","GB00BDT5M118.USD","LU0466842654.USD","LU2461242641.AUD","LU1988902786.USD","LU1064131342.USD","BK4559","LU0689472784.USD","LU0889565916.HKD","LU0256863811.USD","LU0238689110.USD","LU2265009873.SGD","BK4585","LU0097036916.USD","LU2237438978.USD","LU0237698245.USD","IE00B4R5TH58.HKD","LU2491050071.SGD","LU2602419157.SGD","BMY","PFE","IE00BJJMRZ35.SGD","LU1670711123.USD","LU0109391861.USD","LU0640476718.USD","LU1232071149.USD","LU0385154629.USD","LU1032466523.USD","LU2324357040.USD","LU2491050154.USD","LU0786609619.USD","IE00BKDWB100.SGD","LU2360106947.USD","LU1280957306.USD","LU0456855351.SGD","LU1894683264.USD","MTSR","LU0267386448.USD","LU0256863902.USD","LU1585245621.USD","IE00B1BXHZ80.USD","LU0471298694.HKD"],"gpt_icon":0},{"id":"1167503397","title":"Metsera股東初步計票通過輝瑞高達100億美元的收購提案","url":"https://stock-news.laohu8.com/highlight/detail?id=1167503397","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167503397?lang=zh_tw&edition=fundamental","pubTime":"2025-11-13 22:10","pubTimestamp":1763043014,"startTime":"0","endTime":"0","summary":"Metsera股东初步计票显示，支持辉瑞对Metsera Inc.高达100亿美元的收购提案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BLSP4239.USD","LU0225284248.USD","SG9999011175.SGD","SGXZ57979304.SGD","BK4568","BK4599","IE00B19Z3581.USD","PFE","BK4139","LU0289739699.SGD","SG9999013999.USD","IE00BBT3K403.USD","BK4534","LU0321505868.SGD","BK4007","BK4533","LU1023059063.AUD","IE00BLSP4452.SGD","BK4585","SG9999002232.USD","LU0225771236.USD","BK4550","LU0122379950.USD","LU1057294990.SGD","SG9999001176.SGD","LU0306806265.USD","LU1066051498.USD","LU0456855351.SGD","LU0170899867.USD","LU0321505439.SGD","LU0306807586.USD","BK4592","LU1066053197.SGD","SG9999003800.SGD","LU0985481810.HKD","BK4581","LU1883839398.USD","LU1894683264.USD","LU1894683348.USD","LU0234572021.USD","LU0868494617.USD","IE000M9KFDE8.USD","SG9999001176.USD","MTSR","LU0058720904.USD","SG9999002224.SGD","IE00B19Z3B42.SGD","IE0002270589.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":198,"code":"91000000","status":"200"}]}}